CommercialPrior AuthMedium impact
Pharmacy Preauthorizations
EmblemHealth·Pharmacy, Oncology, Infectious Disease +3 more·Pharmacy
We identified it
Jun 20, 2026
Summary
EmblemHealth and ConnectiCare have updated their home infusion therapy drug preauthorization lists. This affects which medications require prior authorization approval before administration or billing.
Action Required
Immediately: Billing and clinical teams must review the updated EmblemHealth/ConnectiCare home infusion therapy preauthorization drug lists at the provided URL. Update internal protocols to ensure prior authorization is obtained for all listed medications before treatment. Verify patient insurance type and obtain required approvals to prevent claim denials.